Shock Inhibition Evaluation With Azimilide - SHIELD

Description:

The goal of the trial was to evaluate treatment with the antiarrhythmic drug azimilide compared with placebo in patients with ventricular arrhythmias already treated with implanted cardioverter defibrillator (ICD) therapy.